|
||||||||||||||||||
| Description and Property Data | Detection | Symptoms and Effects |
| Medical Countermeasures | Physical Contermeasures | Decontamination |
| Common Precursors | Comments and Historical Notes | ICD Codes |
|
CHEMICAL PROTECTIVE ENSEMBLES ARE REQUIRED FOR PROTECTION! | ||
| ||
|
Masks, including self-contained breathing apparatus (SCBA) masks, alone do not
provide adequate protection against this agent for extended periods.
CK may react with the materials in gas mask filters, reducing the useful life of the filter. Evacuate upwind and uphill without moving through the agent cloud.
| ||
| CA Index Name | Cyanogen chloride ((CN)Cl) | ||
| CAS Registry Number | 506-77-4 | RTECS Number | GT2275000 |
Cyanogen chloride is a colorless vapor at normal temperatures, and a clear liquid at low temperatures. While it has an odor that has been variously described as "pungent," "biting," "pepper-like," and "similar to tear gas," the first indication of exposure to cyanogen chloride will usually be tearing and irritation rather than detection of any odor.
| Synonyms: | Chlorine cyanide
Chlorocyan Chlorocyanide Chlorocyanogen Cyanochloride |
CHEMICAL AND PHYSICAL PROPERTIES
Structural Formula
| Molecular Formula |
ClCN | Molecular Weight |
61.47 |
| Boiling Point |
13.8° | Melting Point |
-6° |
| Vapor Density |
2.16 | Liquid Density |
1.19 |
| Vapor Pressure |
1000 mm Hg at 25° | Volatility |
6,132,000mg/m3 at 25°
2,600,000 mg/m3 at 12.8° |
| Nonflammable | |||
| USFA Hazard Ratings | |||
|---|---|---|---|
| (for inhibited cyanogen chloride) | |||
| FIRE 0 |
HEALTH 4 |
REACTIVITY 2 |
SPECIAL |
| UN 1589 (inhibited) |
| ICSC 1053 |
DETECTION
Some blood agent sensitive chemical agent detectors (e.g., MINICAM,
M256A1 sampler-detector) may be used for detection.
Commercial cyanogen chloride detectors
(e.g., gas monitors, Drager tubes, etc.) are also available.
SYMPTOMS AND EFFECTS
Depending on the degree of intoxication, symptoms may include:
Symptoms alone are not usually specific enough to allow definitive diagnosis.
Onset is usually rapid. Effects on inhalation of lethal amounts
may be observed within 15 seconds with death occuring in less
than 10 minutes. Cyanogen chloride should be suspected in terorist
incidents involving prompt fatalities, especially when the
characteristic symptoms of nerve agent intoxication are absent.
CK has lacrimatory and irritant effects that may be noted at
relatively low concentrations. Tearing is commonly seen at
concentrations of 12 mg/m3 or less.
Laboratory Studies
Tests for cyanide in blood and tissues can be confirmatory,
but can take more time than is available for diagnosis in high
exposures. RBC cyanide levels of 0.5-1.0 mcg/mL indicate at
least mild exposure; higher values indicate more significant
exposure.
Other useful laboratory findings
Note: carboxyhemoglobin levels are useful in excluding carbon
monoxide poisoning in situations where smoke inhalation has
occured.
Be aware that effects of this agent may be delayed, especially
if the exposure involved skin contact with the liquid agent. Also
note that very high concentrations of vapor or direct contact with
liquid
are required to produce injury by percutaneous absorption, especially
if exposure times are short.
Remove victims from exposure and decontaminate them as rapidly
as possible. Areas with good air flow should be selected for
triage/prehospital treatment to allow dissipation of vapor from
contaminated individuals. Victims should
not be moved into clean treatment areas where unmasked/ungloved
personnel are working until decontamination is complete.
100% oxygen should be given to all victims of exposure, even
those with very mild symptoms.
Inhalation of cyanogen chloride vapors may produce pulmonary
edema. This should be treated by administering oxygen. For severe
exposure, endotracheal intubation and positive end expiratory pressure (PEEP) ventilation may be appropriate. Other supportive (e.g., bronchodilators and steroids to control bronchospasm) and pallative measures should be employed as needed.
Pulmonary edema may develop relatively late after exposure, so
exposed individuals with indications of respiratory involvement should
be observed for at least 24 hours.
CK liberates cyanide ions, and treatment for exposure to this agent
parallels treatment for cyanide intoxication.
Cyanide is removed by natural metabolic processes, and if
exposure is terminated before it has produced lethal levels in
the blood the prognosis for recovery is very good, even without
antidotal therapy.
Antidotal therapy for symptomatic victims should be
administered as soon as possible.
1. Administer a methemoglobin forming agent:
Sodium bicarbonate should be used to control acidosis in severe poisoning.
An anticonvulsant such as lorazepam (adult 4 mg, pediatric dose
0.1 mg/kg IV or IM in 2-5 minutes, repeat as needed) may be
useful in controlling seizures.
PHYSICAL COUNTERMEASURES
When dealing with victims who have not been decontaminated
protective equipment
including self-contained breathing equipment or gas masks should
be used. Medical personnel treating contaminated victims should avoid
direct (skin-to-skin) contact. Latex
gloves are not adequate protection. Chemical
protective gloves should be used. Casualties should be
decontaminated as rapidly as possible (see the section on
decontamination). Remove casualties from exposure as rapidly as
possible. Casualties must not be moved
into clean treatment areas where unmasked/ungloved personnel are
working until decontamination is complete.
Also refer to
2000 Emergency Response Guidebook (ERG2000) Guide 125.
DECONTAMINATION
Victims
Decontamination of victims is accomplished by removing the
victim from the contaminated area, removal of clothing, and
removal of any agent present on the skin.
Agent on the skin should be promptly removed by
blotting followed by rinsing with copious amounts of soap and water. In
the absence of liquid agent residues, victims should be washed
with copious amounts of water or soap and water for at least 2-3 minutes. Ambulatory
victims and exposed individuals should shower.
Property
Clothing should be washed thoroughly.
Urgent decontamination can be accomplished using soap and water,
collecting the run-off. Cyanogen chloride is nonpersistent, and
decontamination may be accomplished by allowing sufficient time for the
agent to evaporate while monitoring vapor concentrations and restricting access to avoid producing a hazardous situation.
Cyanogen chloride is soluble in water, but hydrolysis is slow.
COMMON PRECURSORS
COMMENTS
Cyanogen chloride may be produced when using bleach-containing decontaminants for decomposition of the nerve agent
GA
Cyanogen chloride is a moderately important industrial chemical,
with uses in synthesis, including the synthesis of herbicides, ore refining, and as a metal cleaner. One of its more interesting uses is as
a warning agent in fumigants, where its ability to irritate at
low concentrations is used to alerts workers to the presence of
hazardous materials that are less noticible.
Because of its industrial utility, cyanogen chloride is a
schedule 3(A) chemical under the Chemical
Weapons Convention, meaning that it can be produced in
large quantities provided that it is not produced for use as a weapon.
Historical Notes
Cyanogen chloride's first reported synthesis was in 1802 by
the French chemist Comte Claude Louis Berthollet.
Like hydrogen cyanide, cyanogen chloride was used during
World War I beginning in July of 1916. Also like hydrogen cyanide,
it was used almost exclusively by the French, who called it
Mauguinite. The British also noted it, assigning the code CC
to the agent (this code was later changed to the now-standard
CK). (The Germans decided to try a related compound, cyanogen bromide.)
The French also produced a mixture they named Vitrite and
designated as 4B. Vitrite consisted of 70% cyanogen chloride with
30% arsenic trichloride, with the arsenic trichloride serving as
a stabilizer to prevent the formation of the trimer.
Cyanogen chloride attracted interest due to its similarity in
its toxic effects to hydrogen cyanide along with its irritating effects
combined with a hope that its greater vapor density
would make it a more effective agent. The agent also tended to break
down the chemicals used to provide protection in the masks of the
time, a quality seen as desirable. Finally, the fact that it didn't
burn up when the burster charge in a shell was seen as giving it
a decided edge over hydrogen cyanide. However, its use was never
widespread.
The "mask breaking" properties of cyanogen chloride (which were
aided by a humid environment) would lead to a resurgence in interest
in the agent during World War II, when the Americans would decide
that it might be useful against the Japanese (whose gas masks lacked
the impregnants that would provide protection against the mask
breaking action of CK). More than 11,000 tons were produced,
but in the event chemical agents were not used by the United
States in this conflict.
After World War II, cyanogen chloride rapidly fell
out of the first line (and even the second line) of chemical weapons
stockpiles, replaced in the favor of military chemical warfare
by the fast acting nerve agents.
Nevertheless, it may still sometimes be stockpiled for use as a
weapon, in part because of the ease with which it can be manufactured
and often in situations where its dual use status as an
industrial chemical and a military agent helps to obfuscate the
purpose of the stockpile.
Terrorists and Cyanogen Chloride
al Qaeda
It has been reported that the al Qaeda terrorist group has
produced and developed plans for the employment of chemical
weapons, including cyanogen chloride.
lacrimation (tearing) bronchorrhea rhinorrhea (running nose) anxiety and/or confusion vertigo nausea with or without vomiting vomiting with or without nausea headache bradypnea followed by apnea hyperpnea followed by apnea convulsions cyanosis (often absent; may be followed by a pink color in the skin) bradycardia cardiac arrest
TOXICITY DATA LD50 Route of
Administrationin
100 mg/kg (liquid)
percutaneous
humans
6 mg/kg
oral
cats
LCt50 Route of
Administrationin
11,000 mg-m-3/min
inhalation
humans
ACGIH TLV
0.3 ppm
(0.6 mg/m3)
NIOSH REL
0.3 ppm
(0.6 mg/m3)
Useful Drugs
Amyl nitrite
Sodium nitrite
Sodium thiosulfate
Endotracheal intubation is indicated for victims who have stopped breathing.
or
2. Administer a sulfur donor to promote conversion of cyanide to thiocyanate:
If needed, the treatments may be repeated one time at half the orignal dose.
Initial Isolation and Protective Action
Distances
SMALL RELEASE
(small
package/leaking container)
First
ISOLATE
in all
directionsThen
PROTECT
persons
downwind duringDAY NIGHT 60 m (200 ft)
0.6 km (0.4 mi)
2.4 km (1.5 mi)
LARGE RELEASE
(large
package/multiple small packages)
First
ISOLATE
in all
directionsThen
PROTECT
persons
downwind duringDAY NIGHT 400 m (1300 ft)
4.0 km (2.5 mi)
8.0 km (5.0 mi)